Objective Cervical cancer (CC) is the fourth most frequent cancer worldwide. Cigarette
smoking has been shown to influence CC risk in conjunction with human papillomavirus …

Cervical cancer, a prevalent gynaecological malignancy, presents challenges in late-stage
treatment efficacy. Aerobic glycolysis, a prominent metabolic trait in cervical cancer …

Background: Cervical cancer is the fourth most common cause of cancer death in women
worldwide. Smoking is one of the risk factors for cervical cancer. Understanding the global …

In this study, a novel, low‐cost, and flexible paper‐based electrochemical immunosensor
was developed for the bioanalysis of Cyfra 21.1 biomarker in human saliva samples by …

Simple Summary This observational study aimed to investigate the possible influence of
sexual behavior and demographic characteristics in the expression of HPV-related …

Aim This study aims to report trends in primary treatment and survival in cervical cancer (CC)
to identify opportunities to improve clinical practice and disease outcome. Methods Patients …

Cervical cancer (CC) constitutes about 70%–80% of squamous cell carcinoma and 10%–
15% of adenocarcinoma. In about 90% of CC cases the Human papillomavirus (HPV) …

Background The prevalence of smoking among cervical cancer survivors is high and
evidence-based smoking cessation interventions are critically needed. This paper describes …

The contribution of the human papillomavirus (HPV) to cancer is significant but not
exclusive, as carcinogenesis involves complex mechanisms, notably oxidative stress …

Abstract Background and Aims Cervical cancer is characterized by abnormal cell growth in
the lining of cervix and it is the second major cause of cancer‐related deaths among females …